Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs
- PMID: 16337206
- DOI: 10.1016/j.ymthe.2005.10.013
Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs
Abstract
Exploiting the RNA interference pathway has shown promise for developing novel and effective treatment of hepatitis B virus (HBV) infection. To advance this approach, we analyzed the antiviral efficacy of a panel of 10 Pol III U6 promoter-encoded short hairpin RNAs (shRNAs) that target conserved sequences of the oncogenic HBx open reading frame. To facilitate intracellular processing, the shRNAs included mismatches in the 25-bp stem region and a terminal loop of miRNA-23. Two shRNAs (shRNA 5 and shRNA 6) showed knockdown of HBV markers by 80-100% in transfected hepatocytes and also in a murine hydrodynamic injection model of HBV replication. Intracellular processing of hairpin RNA with the intended strand bias correlated with antiviral efficacy. Moreover, markers of HBV replication were inhibited without inducing genes associated with the nonspecific interferon response. To assess the antiviral efficacy of the shRNAs in a context that is similar to natural HBV infection, shRNA-encoding cassettes were tested against the virus in a HBV transgenic murine model. When delivered using recombinant adenovirus vectors, U6 shRNA 5 and U6 shRNA 6 mediated significant HBV knockdown. Collectively, these observations indicate that U6 shRNA 5 and U6 shRNA 6 are promising candidates for therapy of chronic HBV infection.
Similar articles
-
[Inhibition of in vitro hepatitis B virus replication by lentivirus-mediated short-hairpin RNA against HBx].Korean J Hepatol. 2009 Mar;15(1):15-24. doi: 10.3350/kjhep.2009.15.1.15. Korean J Hepatol. 2009. PMID: 19346782 Korean.
-
The short hairpin RNA driven by polymerase II suppresses both wild-type and lamivudine-resistant hepatitis B virus strains.Antivir Ther. 2007;12(6):865-76. Antivir Ther. 2007. PMID: 17926641
-
Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice.J Gene Med. 2008 Aug;10(8):878-89. doi: 10.1002/jgm.1207. J Gene Med. 2008. PMID: 18470951
-
Exploiting the RNA interference pathway to counter hepatitis B virus replication.Liver Int. 2005 Feb;25(1):9-15. doi: 10.1111/j.1478-3231.2004.0966.x. Liver Int. 2005. PMID: 15698393 Review.
-
Countering hepatitis B virus infection using RNAi: how far are we from the clinic?Rev Med Virol. 2011 Nov;21(6):383-96. doi: 10.1002/rmv.705. Epub 2011 Sep 13. Rev Med Virol. 2011. PMID: 21913277 Review.
Cited by
-
Supportive Oligonucleotide Therapy (SOT) as a Potential Treatment for Viral Infections and Lyme Disease: Preliminary Results.Infect Dis Rep. 2022 Nov 3;14(6):824-836. doi: 10.3390/idr14060084. Infect Dis Rep. 2022. PMID: 36412742 Free PMC article.
-
The state of gene therapy research in Africa, its significance and implications for the future.Gene Ther. 2017 Sep;24(9):581-589. doi: 10.1038/gt.2017.57. Epub 2017 Jul 10. Gene Ther. 2017. PMID: 28692018 Free PMC article. Review.
-
Type I Interferons Impede Short Hairpin RNA-Mediated RNAi via Inhibition of Dicer-Mediated Processing to Small Interfering RNA.Mol Ther Nucleic Acids. 2017 Mar 17;6:173-182. doi: 10.1016/j.omtn.2016.12.007. Epub 2016 Dec 31. Mol Ther Nucleic Acids. 2017. PMID: 28325284 Free PMC article.
-
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection.Viruses. 2020 Aug 4;12(8):851. doi: 10.3390/v12080851. Viruses. 2020. PMID: 32759756 Free PMC article. Review.
-
Inhibition of highly pathogenic PRRSV replication in MARC-145 cells by artificial microRNAs.Virol J. 2011 Nov 1;8:491. doi: 10.1186/1743-422X-8-491. Virol J. 2011. PMID: 22040357 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
